32.
Gibbins
KJ, Tebo
AE, Nielsen
SK, Branch
DW. Antiphospholipid antibodies in women with severe preeclampsia and
placental insufficiency: a case-control study.
Lupus. 2018 Oct;
27(12):
1903-1910
33. do Prado AD, Piovesan DM, Staub HL, Horta BL. Association of
anticardiolipin antibodies with preeclampsia: A systematic review and
meta-analysis. Obstet Gynecol 2010; 116: 1433–1443
34. Abou-Nassar K, Carrier M, Ramsay T, Rodger MA. The association
between antiphospholipid antibodies and placenta mediated complications:
A systematic review and meta-analysis. Thromb Res 2011; 128: 77–85
35. Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S,
et al. Classical complement activation as a footprint for murine and
human antiphospholipid antibody-induced fetal loss. J Pathol 2011; 225:
502–511.
36. Girardi G, Berman J, Redecha
P, Spruce
L, Thurman
JM, Kraus
D, et al. Complement C5a receptors and neutrophils mediate fetal injury
in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644–1654
37. Holers VM, Girardi G, Mo L,
Guthridge
JM, Molina
H, Pierangeli SS, et al. Complement C3 activation is required for
antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195:
211–220
38. Salmon JE, Girardi G, Holers VM. Activation of complement mediates
antiphospholipid antibody-induced pregnancy loss. Lupus 2003; 12:
535–538
39. Shamonki JM, Salmon JE, Hyjek E, Baergen RN. Excessive complement
activation is associated with placental injury in patients with
antiphospholipid antibodies. Am J Obstet Gynecol 2007; 196: 167. e1–e5.
40. Erkan D, Derksen WJ, Kaplan V,
Sammaritano
L, Pierangeli SS,
Roubey
R, et al. Real world experience with antiphospholipid antibody tests:
how stable are results over time? Ann Rheum Dis 2005; 64: 1321–5.